Skip to main content

Table 1 Sociodemographics, economic characteristics, and clinical history of women with and without uterine fibroids looking for care at Mirebalais University Hospital’s outpatient department between October first, 2019 to January 31, 2020

From: Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study

  Fibroids (Yes)(n = 116) Fibroids (No) (n = 77) P value
characteristics n (%) or mean n (%) or mean  
Age (mean) 41.3 (20–77) 39.4 (22–75) 0.490
Age category    0.013
 20–34 28 (24.1) 31 (40.3)  
 35–49 70 (60.3) 30 (38.9)  
 50+ 18 (15.5) 16 (20.8)  
Number of pregnancies    0.387
 No pregnancy 28 (24.1) 14 (18.2)  
 1–3 pregnancies 52 (44.8) 42 (54.5)  
  > 3 pregnancies 20 (17.2) 11 (14.3)  
Number of births    0.210
 No childbirth 43 (37.1) 22 (28.6)  
 1–3 childbirths 47 (40.5) 41 (53.2)  
  > 3 childbirths 11 (9.5) 5 (6.5)  
Menopause    0.550
 No 81 (69.8) 57 (74.0)  
 Yes 20 (17.2) 11 (14.3)  
Family history of fibroids    < 0.001
 No 25 (21.6) 22 (28.6)  
 Yes 58 (50.0) 10 (12.9)  
Patient status    0.021
 Follow-up visit 95 (81.9) 72 (93.5)  
 Initial visit 21 (18.1) 5 (6.5)  
If follow-up patient    0.051
  < 6 months 8 (5.7) 3 (3.9)  
 6–12 months 15 (9.8) 4 (5.2)  
  > 12 months 72 (70.9) 65 (84.4)  
Zone of Residence    0.009
 Centre 61 (52.6) 55 (71.4)  
 Out of central plateau 55 (47.41) 22 (28.6)  
Type of residence    0.266
 Urban 91 (78.5) 55 (71.4)  
 Rural 25 (21.6) 22 (28.6)  
Average time per medical appointment/visit (Time to go to the hospital)    0.285
  ≤ 2 h 92 (79.3) 65 (84.4)  
  > 2 h 22 (18.9) 10 (12.9)  
Means of transport    0.016
 Public transport 100 (87.1) 55 (71.4)  
 Walk 10 (8.6) 17 (22.1)  
 Private transport 4 (3.5) 5 (6.5)  
Main profession    0.137*
 Small business /market 48 (41.4) 30 (38.9)  
 Educator 15 (12.9) 7 (9.1)  
 Nurse 13 (11.2) 14 (18.2)  
 Farmer 12 (10.3) 2 (2.6)  
 Other 28 (24.1) 24 (31.2)  
Health insurance    0.094
 No 101 (87.1) 60 (77.9)  
 Yes 5 (12.9) 17 (22.1)  
Education    0.036
 Primary 27 (23.3) 9 (11.7)  
 Secondary or higher 74 (63.8) 59 (76.6)  
Family conflicts    0.023
 No 86 (74.1) 67 (87.0)  
 Yes 27 (23.3) 8 (10.4)  
Employment status    0.744
 Not employed 69 (59.5) 47 (61.0)  
 Employed 47 (40.5) 29 (37.7)  
Monthly income    0.255
 15.4 USD - ≤206 USD (≤10 USD/day) 102 (87.9) 73 (94.8)  
  > 206USD (> 10 USD/day) 11 (9.5) 4 (5.2)  
Income decline (decline observed in the income after the diagnosis of uterine fibroids)    < 0.001
 No 49 (42.2) 53 (68.8)  
 yes 67 (57.8) 24 (31.2)  
Degree of income decline if income decline observed    0.560*
 High 49 (61.5) 1 (1.3)  
 Moderate 21 (32.3) 5 (6.5)  
 Low 4 (6.2) 18 (23.4)  
Major expense categories    0.529
 Medical care 23 (19.8) 12 (15.6)  
 Non-medical care 93 (80.2) 65 (84.4)  
Excessive transport expenses    0.001
 No 10 (8.6) 20 (25.9)  
 Yes 91 (78.4) 48 (62.3)  
Clinical diagnostics and complications
 Diagnostic of uterine fibroids
  No 0 (0.0) 77 (39.9)  
  Yes 116 (60.1) 0 (0.0)  
 Anemia    0.789
  No 55 (47.4) 35 (45.4)  
  Yes 61 (52.6) 42 (54.6)  
 Infertility    0.197
  No 73 (62.9) 57 (74.0)  
  Yes 39 (33.6) 20 (25.9)  
 Deep vein thrombosis    0.001
  No 97 (83.6) 76 (98.7)  
  Yes 18 (15.5) 1 (1.3)  
 Urinary stone    0.972
  No 99 (85.3) 65 (84.4)  
  Yes 17 (14.7) 11 (14.3)  
 Hydronephrosis    0.246*
  No 110 (94.8) 76 (98.7)  
  Yes 6 (5.2) 1 (1.3)  
 Pelvic infection    0.168
  No 31 (26.7) 14 (18.2)  
  Yes 82 (70.7) 61 (79.2)  
  1. *p-values generated from Fisher’s exact test for cell counts less than 5